Literature DB >> 30573048

Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.

Michael E Kallen1, Alina Dulau-Florea2, Weixin Wang2, Katherine R Calvo3.   

Abstract

Bone marrow failure and related syndromes are rare disorders characterized by ineffective bone marrow hematopoiesis and peripheral cytopenias. Although many are associated with characteristic clinical features, recent advances have shown a more complicated picture with a spectrum of broad and overlapping phenotypes and imperfect genotype-phenotype correlations. Distinguishing acquired from inherited forms of marrow failure can be challenging, but is of crucial importance given differences in the risk of disease progression to myelodysplastic syndrome, acute myeloid leukemia, and other malignancies, as well as the potential to genetically screen relatives and select the appropriate donor if hematopoietic stem cell transplantation becomes necessary. Flow cytometry patterns in combination with morphology, cytogenetics, and history can help differentiate several diagnostic marrow failure and/or insufficiency entities and guide genetic testing. Herein we review several overlapping acquired marrow failure entities including aplastic anemia, hypoplastic myelodysplasia, and large granular lymphocyte disorders; and several bone marrow disorders with germline predisposition, including GATA2 deficiency, CTLA4 haploinsufficiency, dyskeratosis congenita and/or telomeropathies, Fanconi anemia, Shwachman-Diamond syndrome, congenital amegakaryocytic thrombocytopenia, severe congenital neutropenia, and Diamond-Blackfan anemia with a focus on advances related to pathophysiology, diagnosis, and management. Published by Elsevier Inc.

Entities:  

Keywords:  Aplastic anemia; Bone marrow failure; Flow cytometry; GATA2 deficiency; MDS

Mesh:

Year:  2018        PMID: 30573048     DOI: 10.1053/j.seminhematol.2018.05.016

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  14 in total

1.  Genetic predisposition to MDS: diagnosis and management.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Monitoring and treatment of MDS in genetically susceptible persons.

Authors:  Stella M Davies
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

Authors:  Yash B Shah; Salvatore F Priore; Yimei Li; Chi N Tang; Peter Nicholas; Peter Kurre; Timothy S Olson; Daria V Babushok
Journal:  Blood Adv       Date:  2021-08-24

Review 4.  Distinguishing constitutional from acquired bone marrow failure in the hematology clinic.

Authors:  Emma M Groarke; Neal S Young; Katherine R Calvo
Journal:  Best Pract Res Clin Haematol       Date:  2021-06-02       Impact factor: 3.670

Review 5.  Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.

Authors:  Kristen E Schratz; Amy E DeZern
Journal:  Hematol Oncol Clin North Am       Date:  2020-01-06       Impact factor: 3.722

Review 6.  Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT).

Authors:  Raheel Iftikhar; Parvez Ahmad; Regis de Latour; Carlo Dufour; Antonio Risitano; Naeem Chaudhri; Ali Bazarbachi; Josu De La Fuente; Britta Höchsmann; Syed Osman Ahmed; Usama Gergis; Alaa Elhaddad; Constantijn Halkes; Bassim Albeirouti; Sultan Alotaibi; Austin Kulasekararaj; Hazzaa Alzahrani; Tarek Ben Othman; Simone Cesaro; Ali Alahmari; Rawad Rihani; Salem Alshemmari; Amir Ali Hamidieh; Mohamed-Amine Bekadja; Jakob Passweg; Murtadha Al-Khabori; Walid Rasheed; Andrea Bacigalupo; Qamar-Un-Nisa Chaudhry; Per Ljungman; Judith Marsh; Riad El Fakih; Mahmoud Aljurf
Journal:  Bone Marrow Transplant       Date:  2021-05-19       Impact factor: 5.483

Review 7.  Transcriptional control of blood cell emergence.

Authors:  Sara Menegatti; Marcel de Kruijf; Eva Garcia-Alegria; Georges Lacaud; Valerie Kouskoff
Journal:  FEBS Lett       Date:  2019-08-31       Impact factor: 4.124

8.  Inducible Sbds deletion impairs bone marrow niche capacity to engraft donor bone marrow after transplantation.

Authors:  Ji Zha; Lori K Kunselman; Hongbo M Xie; Brian Ennis; Yash B Shah; Xia Qin; Jian-Meng Fan; Daria V Babushok; Timothy S Olson
Journal:  Blood Adv       Date:  2022-01-11

Review 9.  Immune Phenomena in Myeloid Neoplasms: An "Egg or Chicken" Question.

Authors:  Wilma Barcellini; Bruno Fattizzo
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 10.  When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis.

Authors:  Nicolas Bonadies; Alicia Rovó; Naomi Porret; Ulrike Bacher
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.